ProMIS Neurosciences Inc PMN

Final Drama

[TopBroker]

This is going into phase one clinical and if successful its the end of the road for everyone.

[M101]

I doubt it, but I'd really like to hear your experience or argument. IMO Phase 1 isn't going to answer any key questions unless it's a failure, and given how targeted PMN310 is that seems unlikely. If 70% of phase 1 trials end in success then what is the knowledged gained which finally tips the balance for corporations who have been waiting for this pesky start-up to die? 

[Gbathat]

What do you think the buyout price would be?  Maybe $1B if phase 1 goes well and biomarker data looks good?  Biogen's market cap seemed to swing about 10B on the Phase 3 ups and downs.